269 related articles for article (PubMed ID: 30321638)
1. Modified hyaluronic acid based materials for biomedical applications.
Tiwari S; Bahadur P
Int J Biol Macromol; 2019 Jan; 121():556-571. PubMed ID: 30321638
[TBL] [Abstract][Full Text] [Related]
2. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles.
Cai J; Fu J; Li R; Zhang F; Ling G; Zhang P
Carbohydr Polym; 2019 Mar; 208():356-364. PubMed ID: 30658811
[TBL] [Abstract][Full Text] [Related]
3. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
Oh EJ; Park K; Kim KS; Kim J; Yang JA; Kong JH; Lee MY; Hoffman AS; Hahn SK
J Control Release; 2010 Jan; 141(1):2-12. PubMed ID: 19758573
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of hyaluronic acid as a strategy for the development of advanced drug delivery systems.
Bokatyi AN; Dubashynskaya NV; Skorik YA
Carbohydr Polym; 2024 Aug; 337():122145. PubMed ID: 38710553
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid colloidal gels as self-assembling elastic biomaterials.
Fakhari A; Phan Q; Berkland C
J Biomed Mater Res B Appl Biomater; 2014 Apr; 102(3):612-8. PubMed ID: 24124008
[TBL] [Abstract][Full Text] [Related]
6. Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction.
Kelkar SS; Hill TK; Marini FC; Mohs AM
Acta Biomater; 2016 May; 36():112-21. PubMed ID: 26995504
[TBL] [Abstract][Full Text] [Related]
7. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-fibrin interpenetrating double network hydrogel prepared in situ by orthogonal disulfide cross-linking reaction for biomedical applications.
Zhang Y; Heher P; Hilborn J; Redl H; Ossipov DA
Acta Biomater; 2016 Jul; 38():23-32. PubMed ID: 27134013
[TBL] [Abstract][Full Text] [Related]
9. Characterization of chemisorbed hyaluronic acid directly immobilized on solid substrates.
Suh KY; Yang JM; Khademhosseini A; Berry D; Tran TN; Park H; Langer R
J Biomed Mater Res B Appl Biomater; 2005 Feb; 72(2):292-8. PubMed ID: 15486967
[TBL] [Abstract][Full Text] [Related]
10. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
[TBL] [Abstract][Full Text] [Related]
11. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
[TBL] [Abstract][Full Text] [Related]
12. Current research on hyaluronic acid-drug bioconjugates.
Zhang H; Huang S; Yang X; Zhai G
Eur J Med Chem; 2014 Oct; 86():310-7. PubMed ID: 25173850
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Bioactive Colloidal Gels as Injectable Multiparticle Shedding Platforms.
Freitas B; Lavrador P; Almeida RJ; Gaspar VM; Mano JF
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31282-31291. PubMed ID: 32569459
[TBL] [Abstract][Full Text] [Related]
14. Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers.
Lai JY; Ma DH; Cheng HY; Sun CC; Huang SJ; Li YT; Hsiue GH
J Biomater Sci Polym Ed; 2010; 21(3):359-76. PubMed ID: 20178691
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
Wu J; Zhang J; Deng C; Meng F; Zhong Z
Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
[TBL] [Abstract][Full Text] [Related]
16. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
18. Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa.
Vafaei SY; Esmaeili M; Amini M; Atyabi F; Ostad SN; Dinarvand R
Carbohydr Polym; 2016 Jun; 144():371-81. PubMed ID: 27083829
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
Lin T; Yuan A; Zhao X; Lian H; Zhuang J; Chen W; Zhang Q; Liu G; Zhang S; Chen W; Cao W; Zhang C; Wu J; Hu Y; Guo H
Acta Biomater; 2017 Apr; 53():427-438. PubMed ID: 28213097
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
Choi KM; Jang M; Kim JH; Ahn HJ
Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
